Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

AK5 Inhibitors

AK5 inhibitors refer to a class of chemical compounds that specifically target and inhibit the activity of adenylate kinase 5 (AK5), a member of the adenylate kinase family of enzymes. Adenylate kinases play a pivotal role in cellular energy homeostasis by catalyzing the reversible transfer of phosphate groups between adenosine triphosphate (ATP) and adenosine monophosphate (AMP) to regulate cellular nucleotide balance. AK5, in particular, is found primarily in the brain and has been shown to contribute to cellular processes related to energy metabolism, signal transduction, and metabolic stress response. Inhibition of AK5 can lead to alterations in ATP-AMP ratios and disrupt the energy balance within cells, thereby affecting various energy-dependent pathways. The intricate control of ATP levels is crucial for maintaining normal cellular function, as ATP is the primary energy currency of the cell. By inhibiting AK5, researchers are able to modulate key biochemical reactions involved in the energetics of specialized cells, particularly neurons.

Structurally, AK5 inhibitors are designed to interact with the catalytic domain of the AK5 enzyme, specifically binding to its active site and preventing its phosphate transfer activity. The active site of AK5 shares a highly conserved motif with other members of the adenylate kinase family, making the design of specific inhibitors a significant challenge due to potential cross-reactivity with other isoforms like AK1 or AK2. Chemical synthesis of these inhibitors often involves fine-tuning structural features to enhance selectivity, potency, and binding affinity for AK5 over other related kinases. Studying the molecular interactions between AK5 and its inhibitors offers valuable insights into how enzyme inhibition alters cellular biochemical pathways, making this an area of significant interest in biochemical and molecular biology research. Advanced spectroscopic and crystallographic methods are typically employed to understand how these inhibitors fit within the enzyme's active site, providing detailed information on binding modes and conformational changes upon inhibition.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Apigenin

520-36-5sc-3529
sc-3529A
sc-3529B
sc-3529C
sc-3529D
sc-3529E
sc-3529F
5 mg
100 mg
1 g
5 g
25 g
100 g
1 kg
$33.00
$214.00
$734.00
$1151.00
$2348.00
$3127.00
$5208.00
22
(1)

Inhibits CK2 kinase, which phosphorylates AK5. Reduced phosphorylation decreases AK5 activity in ATP production.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

PI3K inhibitor affecting AKT phosphorylation, which in turn affects AK5's capability to sustain cellular ATP levels.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor that affects AKT, indirectly causing a decrease in AK5-mediated ADP to ATP conversion.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Broad kinase inhibitor that includes CK2, thereby reducing AK5 phosphorylation and function.

Allopurinol

315-30-0sc-207272
25 g
$131.00
(0)

Inhibits xanthine oxidase, reducing the availability of substrates for AK5 catalytic activity.

GW 5074

220904-83-6sc-200639
sc-200639A
5 mg
25 mg
$106.00
$417.00
10
(1)

c-Raf inhibitor that alters MAPK signaling. This affects ERK and subsequently modulates AK5 function.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Tyrosine kinase inhibitor that can affect AK5 by disrupting phosphorylation pathways linked to ATP production.

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$110.00
$250.00
$936.00
$50.00
33
(2)

Inhibits CK2 and affects AK5 by reducing its phosphorylation, thereby affecting its ATP generating capability.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

mTOR inhibitor affecting cellular energy metabolism, thereby indirectly reducing the need for AK5 catalytic action.

AICAR

2627-69-2sc-200659
sc-200659A
sc-200659B
50 mg
250 mg
1 g
$65.00
$280.00
$400.00
48
(2)

AMPK activator affecting cellular ATP needs, thus indirectly affecting AK5's role in ATP balance.